IRADIMED CORPORATION provided revenue guidance for the second quarter and full year of 2024. For the second quarter of 2024, the Company expects to report revenue of $17.6 million to $17.8 million, GAAP diluted earnings per share of $0.33 to $0.36.

For the year, the company reiterates to report revenue of $72.0 million to $74.0 million, GAAP diluted earnings per share of $1.37 to $1.47.